Archive for December, 2013

Right Turn: Stem cells at the movies

Author: Stacey Johnson, 12/27/13

  If you are fortunate enough to have time off over the holiday season, I’ll wager that you may spend some of that time in front of the television. Call me a Grinch, but Christmas TV programming is something that I generally avoid. If, like me, you plan on skipping “National Lampoon’s Christmas Vacation,” “Christmas…Read more

Stem cells in 60 seconds: Quick lessons in communicating science

Author: Angela C. H. McDonald, 12/23/13

> Last Friday afternoon, I raced over to a University of Toronto neighbourhood pub for the annual Ontario Stem Cell Initiative (OSCI) holiday party. This year, OSCI decided to change up the usual scientific poster session and created a science communication competition — right up my alley. The competition was called “Stem Cells in Sixty…Read more

Right Turn: The ultimate Christmas present

Author: Stacey Johnson, 12/20/13

. With five days left to go until Christmas, are you feeling stressed about that hard-to-buy-for person on your Christmas list? Don’t despair. I have scoured the Internet on your behalf and found the perfect gift for the scientist in your life or the person who loves a scientist. Drum roll, please…It’s the human embryonic…Read more

“Freedom to operate” strategy positions BioTime for rapid growth

Author: Paul Krzyzanowski, 12/16/13

> This is part three of an interview series with Michael West, CEO of BioTime. Read parts one and two.  The prospects for BioTime and other companies that operate in the tissue engineering and cell therapy market are good. The industry is growing by about 18% per year and is estimated to reach $11 billion…Read more

Right Turn: Regenerative Architecture?

Author: Patrick Blit, 12/13/13

. Regenerative architecture is an architectural discipline that explores the use of novel designs for the goal of producing sustainable structures that minimize the impact on our planet. You’re probably thinking that bamboo flooring is an example of this and you wouldn’t be completely wrong. In a 2010 TED talk, architect, designer and all-around creative…Read more

Value-Based Pricing in regenerative medicine: You get what you pay for

Author: Natasha Davie, 12/10/13

. The UK has previously committed to incorporating some sort of value based pricing into its reimbursement scheme to improve patient access to innovative medicines. With recent backtracking on this decision, as the Jan 2014 deadline for this integration approaches, we examine how such a decision would impact regenerative medicine. The cost of health care…Read more

A Californian approach to working with patient advocates

Author: Lisa Willemse, 12/06/13

> To be, or not to be, that is the question: Whether ’tis Nobler in the mind to suffer The Slings and Arrows of outrageous Fortune, Or to take Arms against a Sea of troubles, And by opposing end them We know this famous soliloquy from Shakespeare’s Hamlet, but the words take on a different…Read more

Right Turn: The colon, untangled

Author: Lisa Willemse, 12/06/13

> I’ve been thinking a lot about cancer lately: the mother of a good friend of mine is in the last stages of a terminal battle with pancreatic cancer and my godfather, a man with whom I share fond memories of practical jokes and summer farm vacations, was recently diagnosed with inoperable stomach cancer. I’m…Read more

Cardiac regenerative medicine update from the World Stem Cell Summit

Author: Ben Paylor, 12/05/13

> Just over two years ago I wrote about early reports from Dr. Roberto Bolli et al.’s SCIPIO trial running out of the University of Louisville in collaboration with the Harvard Medical School. Since this time, much has happened in the realm of cell therapy to treat ischemic cardiomyopathy and I was able to get…Read more

Why clinical translation is key to CIRM’s quest for more funding

Author: Nick Dragojlovic, 12/02/13

> As the expiration of the California Institute for Regenerative Medicine’s (CIRM) funding approaches, the fate of CIRM after 2017 is top of mind for stem cell researchers in the state. While the agency’s leadership appears to be leaning towards some form of public-private partnership, planning for its financial future has reportedly assumed the future…Read more